Brain data company Rune Labs raised a $12 million Series A extension, CEO Brian Pepin tells Axios exclusively.
Why it matters: Symptom tracking for neurological disorders like Parkinson's may help patients and providers manage the disease more precisely, or even underwrite new drug candidates.
